secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avid Bioservices, Inc. (—)
CIK:        0000704562
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001683168-24-001433
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Avid restates financials after $1.4M note default; material weakness found
--------------------------------------------------------------------------

- Holder of ≥25% of 1.250% Exchangeable Senior Notes due 2026 accelerated all notes due to missed legend removal and unpaid Additional Interest at 0.50% p.a.
- Additional Interest accrued totaled approximately $1.4 million through February 29, 2024, triggering an event of default.
- Audit Committee determined financial statements in Qs ending Oct 2022, Jan, Jul, Oct 2023 and FY 2023 are no longer reliable.
- Company identified a material weakness in internal control over financial reporting related to note classification and disclosure.
- Restated financials for affected periods will be filed via an amendment to FY 2023 10-K as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704562/000168316824001433/0001683168-24-001433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704562/000168316824001433/avid_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer